Announcement on Implementation of Dividend Distribution for Q3 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Dividend Distribution for Q3 2025
Filed with SSE · · 3 pages · Chinese
Release
Yabao Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Yabao Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Progress in the Sale of Subsidiary Equity and Completion of Industrial and Commercial Registration Change
- Announcement on Profit Distribution Plan for Q3 2025
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials of GLX002
- Announcement on the Change of Signatory Certified Public Accountant and Quality Control Reviewer for the Audit Institution
Later from Yabao Pharmaceutical
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Resolutions of the 13th Meeting of the 9th Board of Directors
- Announcement on Purchasing Liability Insurance for Directors and Senior Management Members
- Announcement on Attending 2026 Online Collective Reception Day for Investors of Listed Companies in Shanxi Jurisdiction
- Announcement on the Wholly-owned Subsidiary Obtaining Drug Registration Certificate
Follow Yabao Pharmaceutical into a list and get an email when it puts out news.
Follow Yabao Pharmaceutical